ScienceDaily: Top Health News |
Immune cells produce chemical messenger that prevents heart disease–related inflammation Posted: 29 Mar 2022 03:54 PM PDT |
Universal flu vaccine candidate Posted: 29 Mar 2022 03:53 PM PDT Scientists have leveraged on a novel vaccine platform to deliver M2e to immune cells. This allowed them to prove that a single shot immunization containing M2e was able to trigger long-lasting immune responses that could protect effectively against multiple strains of the flu. The team was also able to demonstrate that this vaccination approach significantly enhanced protective immune responses in the context of pre-existing flu immunity. This scenario is particularly relevant in adult and elderly populations, where individuals have been exposed to flu viruses multiple times in the past and have low levels of M2e-specific antibodies in their blood circulation. |
Posted: 29 Mar 2022 12:28 PM PDT |
Researchers identify key complex for ribosome generation Posted: 29 Mar 2022 11:25 AM PDT Researchers have identified a four-protein complex that appears to play a key role in generating ribosomes -- organelles that serve as protein factories for cells -- as well as a surprising part in neurodevelopmental disorders. The findings could lead to new ways to manipulate ribosome production, which could impact a variety of conditions that affect human health. |
Head-mounted microscope reaches deeper into mouse brains Posted: 29 Mar 2022 11:25 AM PDT Researchers have developed a miniature microscope that is designed for high-resolution 3D images inside the brains of living mice. The new, lightweight design could help scientists understand how brain cells operate by imaging deeper into the brain than previously possible with miniature widefield microscopes. |
Roundworms’ egg cells have a backup plan Posted: 29 Mar 2022 11:25 AM PDT |
Posted: 29 Mar 2022 11:25 AM PDT Scientists show that responses to the Pfizer-BioNTech BNT162b2 mRNA vaccine differ significantly in individuals based on whether or not they were previously infected with SARS-CoV-2. Notably, those who had COVID before vaccination experienced rapid antibody production after the first vaccine dose, with little or no increase after the second dose. The opposite pattern was observed in infection-naive individuals. |
Study finds 10-second videos predict blood cancer relapse Posted: 29 Mar 2022 11:25 AM PDT |
How accelerated biological aging may cause bowel cancer Posted: 29 Mar 2022 08:47 AM PDT |
Sensor for faster, more accurate COVID-19 tests Posted: 29 Mar 2022 08:47 AM PDT |
Newly discovered drug candidate increased insulin secretion in type 2 diabetes Posted: 29 Mar 2022 08:47 AM PDT Researchers have discovered increased levels of of a microRNA in type 2 diabetes, which has a negative effect on insulin secretion. Their experiments on human insulin producing cells in the pancreas also demonstrates that it is possible to increase the insulin secretion by reducing the levels of this microRNA. An important goal of the research is to develop new treatments for people with the disease. |
Posted: 29 Mar 2022 08:47 AM PDT A new study reports that, among youth with substance use and depression, a significant proportion show early improvements in depression during their treatment for substance use. Youth who are using cannabis less frequently prior to treatment and those without conduct disorder are more likely to experience early depression improvement. |
Researchers expand target range of CRISPR/Cas Systems Posted: 29 Mar 2022 08:47 AM PDT |
Researchers shorten manufacturing time for CAR T cell therapy Posted: 29 Mar 2022 08:47 AM PDT A new approach could cut the time it takes to alter patients' immune cells for infusion back into the body to find and attack cancer. The cell manufacturing process for this type of immunotherapy that was pioneered at Penn -- CAR T cell therapy -- typically takes nine to 14 days. In a pre-clinical study, scientists have abbreviated this process and generated functional CAR T cells with enhanced anti-tumor potency in just 24 hours. |
Promising Alzheimer's drug may also improve memory in Down syndrome and normal aging Posted: 29 Mar 2022 08:47 AM PDT New research is breaking ground in repurposing an FDA-approved drug as a potential treatment in Down syndrome and normal aging. The results suggest that GM-CSF may improve cognitive function in people with Down syndrome. The drug sargramostim (GM-CSF, which stands for granulocyte-macrophage colony-stimulating factor) is also the first to show memory improvement in Alzheimer's patients in a phase II clinical trial. GM-CSF is a normal human protein that is safe and well-tolerated with over 30 years of FDA-approved use for other disorders. |
Lung damage may persist long after COVID-19 pneumonia Posted: 29 Mar 2022 08:47 AM PDT |
AI helps radiologists detect bone fractures Posted: 29 Mar 2022 08:47 AM PDT |
Posted: 29 Mar 2022 08:47 AM PDT |
Good hydration may reduce long-term risks for heart failure Posted: 29 Mar 2022 08:47 AM PDT |
Researchers redefine the mechanisms of Dravet syndrome Posted: 29 Mar 2022 08:46 AM PDT |
Folding design leads to heart sensor with smaller profile Posted: 29 Mar 2022 08:46 AM PDT Researchers want to leverage the centuries-old art of cutting paper, kirigami, into designs to develop a sensor sheet that can stretch and breathe with the skin while collecting electrocardiographic data. Scientists in Japan use cuts in a film made of polyethylene terephthalate printed with silver electrodes to fit a sensor on a person's chest to monitor his or her heart. At the optimal size found, they were able to detect enough signal from the heart to be used in a smartphone app. |
Osmotic pressure and viscosity: Anticancer drug efficacy and restricting tumors using LDDS Posted: 29 Mar 2022 07:00 AM PDT Chemotherapy is known for its painful side-effects. It also has limitations when the cancer has metastasized to the lymph nodes. The lymphatic drug delivery system, where anticancer drugs are injected directly into the sentinel lymph nodes under ultrasound guidance, offers an alternative to conventional chemotherapy. Researchers have now found the optimal osmotic pressure and viscosity ranges, significantly improving the antitumor effect. |
An approach to treating a severe congenital myopathy Posted: 29 Mar 2022 07:00 AM PDT |
I was here first! This is how hepatitis C inhibits hepatitis E Posted: 29 Mar 2022 06:07 AM PDT Infections with hepatitis C and E are so common that, going only by statistics, many people should be infected with both viruses at the same time. However, only very few such cases have been reported. A research team has a guess as to why this is the case: The researchers found that the viruses inhibit each other when they infect at the same time. |
Posted: 29 Mar 2022 06:07 AM PDT Police and fire first responders are often first on the scene during an out-of-hospital cardiac arrest, and a new study finds that their intervention correlates with significantly higher chances of patient survival and hospital discharge with good neurological outcomes. Researchers say non-medical first responders are likely underutilized as lifesaving resources in these cases. |
Rehabilitation psychologists: Specialists you may not yet know, but might one day need Posted: 29 Mar 2022 06:07 AM PDT Rehabilitation psychology is a field that focuses on assessing and treating cognitive, emotional and functional difficulties for patients in a rehabilitation setting. In a recent state of the field survey paper, researchers conclude that providers need to communicate the value they bring to organizations through saving costs from decreased hospitalizations, assessing the likelihood of successful interventions and recovery, and more. Authors also call for broad and simultaneous promotion and recruitment in the field. |
Posted: 29 Mar 2022 06:07 AM PDT |
Potential window for treating ALS identified Posted: 29 Mar 2022 06:07 AM PDT Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder that affects as many as 30,000 people in the United States, with 5,000 new cases diagnosed each year. It weakens muscles over time, impacting physical function and ultimately leading to death. There is no single cause for the disease and no known cure. However, researchers have found a possible window of opportunity during ALS treatment to target astrocyte abnormalities. |
Researchers use skull CT scans to estimate assigned sex at birth Posted: 28 Mar 2022 08:25 AM PDT |
More older adults getting treated for substance abuse Posted: 28 Mar 2022 08:23 AM PDT |
Evidence of brain changes in those at risk of bipolar disorder captured with MRI scans Posted: 28 Mar 2022 06:20 AM PDT |
Stroke treatments safe and effective for people with existing disability or dementia, study suggests Posted: 28 Mar 2022 06:00 AM PDT A research review found that clot-busting therapy and mechanical clot removal to treat ischemic stroke in people with a pre-existing disability or dementia was as safe and effective as in adults without those conditions. These treatments are key to preventing additional disability. A person's pre-existing disabilities or dementia may cloud the stroke assessment process, which may lead to clinicians thinking the stroke is more severe and beyond the window for optimal treatment. This often results in delayed treatment or no treatment. People with a disability or dementia should be included in randomized controlled trials for stroke treatment. Currently, evidence-based stroke treatment data and guidance for people with disability or dementia are extremely limited. |
You are subscribed to email updates from Top Health News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |